Articles tagged as


  • Signal from Noise
May 20, 2020

-HZNP’s Tepezza drug for thyroid eye disease showed stronger than expected 1Q20 growth -Even after a post-1Q20 report jump, HZNP shares still reasonable value vs growth potential -Both Tepezza an Krystexxa medicines show promise; stock could rise up to 30% If the stock market recovery is for real, and we think it is, some investors...

Horizon Therapeutics Is Inexpensive; 2 Drugs Show Promise
FSInsight logo
150 East 52nd St, 3rd Floor, New York, NY 10022

Subscribe to our Free Weekly Report

An insitutional-grade report delivered to your inbox every week.

© 2021 FSInsight. All rights reserved. Developed by HANGAR115.

Illustrations by Karl Wimer.